NET PROFIT (x1000 NOK)
EMPLOYEES
NXbio Development AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
2,748
|
1,787
|
3,175 |
Earnings before taxes |
-46,454
|
-18,486
|
-28,476 |
EBITDA |
-144
|
-157
|
-42 |
Total assets |
130,603
|
192,264
|
161,486 |
Current assets |
130,502
|
192,170
|
161,389 |
Current liabilities |
131
|
58
|
36 |
Equity capital |
82,405
|
120,000
|
142,777 |
- share capital |
3,824
|
3,571
|
3,681 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.1%
|
62.4%
|
88.4% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-33.5%
|
-8.7%
|
-15.7% |
Current ratio |
99619.8%
|
331327.6%
|
448302.8% |
Return on equity (ROE) |
-56.4%
|
-15.4%
|
-19.9% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
|
2 |
Chg. No. of employees % |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.